Maha Cabinet Nod To Expand Govt Cancer Hospital, Aurangabad To 265-Bed Facility
Mumbai: The Maharashtra Cabinet on Wednesday gave its approval for the expansion of Government Medical College and Cancer Hospital at Aurangabad.
As a result, the 100-bed hospital will be expanded to 265 beds at cost of around Rs 25 crore, an official press statement stated.
After being recognized as a State Cancer Institute as per Government Resolution of Oct 15, 2016, GMCCH will provide treatment for cancer patients from Marathwada in Aurangabad itself.
Also Read:Maha: Medicos, parents demand waiver in hostel, mess charges at medical colleges
For the expanded facility, 316 regular posts of Group-A to Group-D and 360 posts of 44 external posts will be filled.
The issue was resolved due to repeated follow-up by Aurangabad Guardian Minister Subhash Desai.
For this, Mr Desai held meetings with Health Minister Rajesh Tope and Medical Education Minister Amit Deshmukh, it was stated.
Also Read:Maha: Online fraudsters cheat man of Rs 10 lakh in promise of medical admissions for son, probe on
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!